LifePoint Health:企業の戦略・SWOT・財務情報

◆英語タイトル:LifePoint Health - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1933
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

LifePoint Health – Strategy, SWOT and Corporate Finance Report
Summary

LifePoint Health – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

LifePoint Health (LifePoint or ‘the company’) is involved in operating community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in non-urban markets. It primarily offers medical and surgical services, rehabilitation services, pediatric services, specialized services and outpatient services. The company aims to provide quality health services in various communities and also provides necessary equipment’s and resources to various physicians. LifePoint is headquartered in Brentwood, Tennessee, the US.

Scope

- Detailed information on LifePoint Health required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LifePoint Health in the form of a SWOT analysis
- An in-depth view of the business model of LifePoint Health including a breakdown and examination of key business segments
- Intelligence on LifePoint Health’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LifePoint Health, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LifePoint Health and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LifePoint Health as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LifePoint Health’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
LifePoint Health: Company Overview 9
LifePoint Health: Overview and Key Facts 9
LifePoint Health: Overview 9
LifePoint Health: Key Facts 9
LifePoint Health: Key Employees 11
LifePoint Health: Key Employee Biographies 12
LifePoint Health: Major Products and Services 17
LifePoint Health: Company History 18
LifePoint Health: Management Statement 25
LifePoint Health: Locations and Subsidiaries 27
LifePoint Health: Key Competitors 28
LifePoint Health: Company Analysis 29
LifePoint Health: Business Description 29
LifePoint Health: SWOT Analysis 30
LifePoint Health: SWOT Overview 30
LifePoint Health: Strengths 30
LifePoint Health: Weaknesses 31
LifePoint Health: Opportunities 31
LifePoint Health: Threats 32
LifePoint Health: Corporate Financial Deals Activity 34
LifePoint Health: Financial Deals Overview 34
LifePoint Health: Targets and Partners 36
LifePoint Health: Top Deals 2014 – 2018YTD* 37
LifePoint Health: Mergers and Acquisitions 38
LifePoint Health: Capital Raising 39
LifePoint Health: Partnership 40
LifePoint Health: Divestments 41
LifePoint Health: Recent Developments 42
LifePoint Health: News and Events Summary 42
LifePoint Health: Business Expansion 45
LifePoint Health: Contracts 45
LifePoint Health: Corporate Governance 46
LifePoint Health: Financial Deals 46
LifePoint Health: Financial Performance 46
LifePoint Health: Red Flags/DistressSignals 47
LifePoint Health: Regulatory and Legal Events 48
LifePoint Health: Strategy and Operations 48
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: LifePoint Health: Key Facts
Table 2: LifePoint Health: Key Employees
Table 3: LifePoint Health: Locations and Subsidiaries
Table 4: LifePoint Health: Key Competitors
Table 5: LifePoint Health: Deal Activity by Deal Type - Volume (TTM*)
Table 6: LifePoint Health: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: LifePoint Health: Targets and Partners
Table 8: LifePoint Health: Top Deals 2014 - 2018YTD*
Table 9: LifePoint Health: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: LifePoint Health: M&A Activity by Geography (2014 - YTD*2018)
Table 11: LifePoint Health: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: LifePoint Health: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: LifePoint Health: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: LifePoint Health: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: LifePoint Health: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: LifePoint Health: Divestments by Geography (2014 - YTD*2018)
Table 17: LifePoint Health: News and Events Summary
Table 18: LifePoint Health: Business Expansion
Table 19: LifePoint Health: Contracts
Table 20: LifePoint Health: Corporate Governance
Table 21: LifePoint Health: Financial Deals
Table 22: LifePoint Health: Financial Performance
Table 23: LifePoint Health: Red Flags/DistressSignals
Table 24: LifePoint Health: Regulatory and Legal Events
Table 25: LifePoint Health: Strategy and Operations

List of Figures
Figure 1: LifePoint Health: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: LifePoint Health: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: LifePoint Health: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: LifePoint Health: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: LifePoint Health: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: LifePoint Health: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: LifePoint Health: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: LifePoint Health: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: LifePoint Health: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: LifePoint Health: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[LifePoint Health:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務情報
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • The Bank of Kochi, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Kochi, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Kochi, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • KELAG-Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    KELAG-Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • SFJ Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SFJ Pharmaceuticals Inc (SFJ Pharmaceuticals) is a pharmaceutical company that offers drug development services. The company provides management of phase III oncology clinical trials, phase III trials and regulatory approvals. It offers phase III trials for kidney cancer, lung cancer and aut …
  • Dycom Industries Inc (DY):企業の財務・戦略的SWOT分析
    Summary Dycom Industries Inc (Dycom Industries) is a technology company that provides contracting services. The company offers services to the telecommunications and infrastructure industries. It provides contracting services such as construction, locating, engineering, fulfilment, programs manageme …
  • Prothena Corp Plc (PRTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Omnova Solutions Inc (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Energa SA (ENG):企業の財務・戦略的SWOT分析
    Energa SA (ENG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • KYORIN Holdings Inc (4569):企業の財務・戦略的SWOT分析
    KYORIN Holdings Inc (4569) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Optum Inc-医療機器分野:企業M&A・提携分析
    Summary Optum Inc (Optum), a subsidiary of UnitedHealth Group Inc is a healthcare service provider that offers health IT, pharmacy care services, population health management, data and analytics, financial services, health care delivery, revenue cycle management, and health plan operations. The comp …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆